NO20055207L - Oralt farmasoytisk preparat for protonpumpeantagonister - Google Patents
Oralt farmasoytisk preparat for protonpumpeantagonisterInfo
- Publication number
- NO20055207L NO20055207L NO20055207A NO20055207A NO20055207L NO 20055207 L NO20055207 L NO 20055207L NO 20055207 A NO20055207 A NO 20055207A NO 20055207 A NO20055207 A NO 20055207A NO 20055207 L NO20055207 L NO 20055207L
- Authority
- NO
- Norway
- Prior art keywords
- proton pump
- pharmaceutical preparation
- oral pharmaceutical
- pump antagonists
- antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Oppfirmelsen vedrører nye doseringsformer for protonpumpeantagonister.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10317023A DE10317023A1 (de) | 2003-04-11 | 2003-04-11 | Perorale Arzneimittelzubereitung für Protonenpumpenantagonisten |
EP03008453 | 2003-04-11 | ||
PCT/EP2004/050493 WO2004089342A2 (en) | 2003-04-11 | 2004-04-08 | Oral pharmaceutical preparation comprising a proton pump antagonist and a basic exipient |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20055207L true NO20055207L (no) | 2005-11-04 |
Family
ID=33160619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20055207A NO20055207L (no) | 2003-04-11 | 2005-11-04 | Oralt farmasoytisk preparat for protonpumpeantagonister |
Country Status (19)
Country | Link |
---|---|
US (1) | US20060204568A1 (no) |
EP (1) | EP1615624A2 (no) |
JP (1) | JP2006522776A (no) |
KR (1) | KR20060002932A (no) |
AR (1) | AR044004A1 (no) |
AU (1) | AU2004228961A1 (no) |
BR (1) | BRPI0409175A (no) |
CA (1) | CA2526869A1 (no) |
CL (1) | CL2004000767A1 (no) |
EA (1) | EA200501565A1 (no) |
IS (1) | IS8107A (no) |
MA (1) | MA27772A1 (no) |
MX (1) | MXPA05010705A (no) |
NO (1) | NO20055207L (no) |
PE (1) | PE20050414A1 (no) |
RS (1) | RS20050756A (no) |
TN (1) | TNSN05233A1 (no) |
TW (1) | TW200503783A (no) |
WO (1) | WO2004089342A2 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20050150A1 (es) * | 2003-05-08 | 2005-03-22 | Altana Pharma Ag | Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo |
JP2008515787A (ja) * | 2004-10-05 | 2008-05-15 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | プロトンポンプアンタゴニストと塩基性賦形剤とを含有する経口医薬調剤 |
US20080194307A1 (en) * | 2007-02-13 | 2008-08-14 | Jeff Sanger | Sports-based game of chance |
PT2952177T (pt) | 2007-10-12 | 2021-04-26 | Novartis Ag | Composições compreendendo moduladores do recetor de fosfato de esfingosina 1 (s1p) |
US20100048524A1 (en) | 2008-03-14 | 2010-02-25 | Angela Brodie | Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity |
ES2660962T3 (es) | 2008-07-28 | 2018-03-26 | Takeda Pharmaceutical Company Limited | Composición farmacéutica fotoestabilizada |
EP3288556A4 (en) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
TWI710379B (zh) | 2015-07-30 | 2020-11-21 | 日商武田藥品工業股份有限公司 | 錠劑 |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4464372A (en) * | 1982-08-16 | 1984-08-07 | Schering Corporation | Imidazo[1,2-b]pyridazines |
GB8422461D0 (en) * | 1984-09-05 | 1984-10-10 | Wyeth John & Brother Ltd | Pyridine derivatives |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
US4833149A (en) * | 1986-09-22 | 1989-05-23 | Ortho Pharmaceutical Corporation | 2- or 3-aryl substituted imidazo[1,2-a]pyridines |
US5041442A (en) * | 1990-07-31 | 1991-08-20 | Syntex (U.S.A.) Inc. | Pyrrolo(1,2-a)pyrazines as inhibitors of gastric acid secretion |
US5362743A (en) * | 1993-03-09 | 1994-11-08 | Pfizer Inc. | Aminoquinoline derivatives |
US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
PT971922E (pt) * | 1997-03-24 | 2004-09-30 | Altana Pharma Ag | Compostos de tetra-hidropirido |
WO1998050019A1 (en) * | 1997-05-09 | 1998-11-12 | Sage Pharmaceuticals, Inc. | Stable oral pharmaceutical dosage forms |
TW580397B (en) * | 1997-05-27 | 2004-03-21 | Takeda Chemical Industries Ltd | Solid preparation |
ID28896A (id) * | 1998-09-23 | 2001-07-12 | Byk Gulden Lomberg Chem Fab | Tetrahidro pirido eter |
PT1187601E (pt) * | 1999-06-07 | 2005-11-30 | Altana Pharma Ag | Nova forma de preparacao e a administracao compreendendo um inibidor da bomba de protoes instavel em meio acido |
DE19925710C2 (de) * | 1999-06-07 | 2002-10-10 | Byk Gulden Lomberg Chem Fab | Neue Zubereitung und Darreichungsform enthaltend einen säurelabilen Protonenpumpenhemmer |
IL130602A0 (en) * | 1999-06-22 | 2000-06-01 | Dexcel Ltd | Stable benzimidazole formulation |
CA2387746C (en) * | 1999-10-20 | 2010-06-29 | Koji Ukai | Methods for stabilizing benzimidazole-based compounds |
UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
US20040028737A1 (en) * | 2002-08-12 | 2004-02-12 | Kopran Research Laboratories Limited | Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same |
-
2004
- 2004-04-01 TW TW093109111A patent/TW200503783A/zh unknown
- 2004-04-07 PE PE2004000357A patent/PE20050414A1/es not_active Application Discontinuation
- 2004-04-07 AR ARP040101186A patent/AR044004A1/es not_active Application Discontinuation
- 2004-04-08 BR BRPI0409175-2A patent/BRPI0409175A/pt not_active IP Right Cessation
- 2004-04-08 EP EP04726521A patent/EP1615624A2/en not_active Withdrawn
- 2004-04-08 RS YUP-2005/0756A patent/RS20050756A/sr unknown
- 2004-04-08 KR KR1020057018865A patent/KR20060002932A/ko not_active Application Discontinuation
- 2004-04-08 US US10/551,943 patent/US20060204568A1/en not_active Abandoned
- 2004-04-08 EA EA200501565A patent/EA200501565A1/ru unknown
- 2004-04-08 WO PCT/EP2004/050493 patent/WO2004089342A2/en active Application Filing
- 2004-04-08 CA CA002526869A patent/CA2526869A1/en not_active Abandoned
- 2004-04-08 JP JP2006505541A patent/JP2006522776A/ja not_active Withdrawn
- 2004-04-08 AU AU2004228961A patent/AU2004228961A1/en not_active Abandoned
- 2004-04-08 CL CL200400767A patent/CL2004000767A1/es unknown
- 2004-04-08 MX MXPA05010705A patent/MXPA05010705A/es unknown
-
2005
- 2005-09-23 TN TNP2005000233A patent/TNSN05233A1/en unknown
- 2005-10-31 IS IS8107A patent/IS8107A/is unknown
- 2005-11-02 MA MA28575A patent/MA27772A1/fr unknown
- 2005-11-04 NO NO20055207A patent/NO20055207L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2006522776A (ja) | 2006-10-05 |
WO2004089342A3 (en) | 2005-03-10 |
US20060204568A1 (en) | 2006-09-14 |
WO2004089342A2 (en) | 2004-10-21 |
BRPI0409175A (pt) | 2006-04-11 |
AU2004228961A1 (en) | 2004-10-21 |
TW200503783A (en) | 2005-02-01 |
MA27772A1 (fr) | 2006-02-01 |
RS20050756A (en) | 2007-11-15 |
EA200501565A1 (ru) | 2006-06-30 |
IS8107A (is) | 2005-10-31 |
TNSN05233A1 (en) | 2007-06-11 |
EP1615624A2 (en) | 2006-01-18 |
KR20060002932A (ko) | 2006-01-09 |
CA2526869A1 (en) | 2004-10-21 |
CL2004000767A1 (es) | 2005-05-27 |
PE20050414A1 (es) | 2005-06-18 |
AR044004A1 (es) | 2005-08-24 |
MXPA05010705A (es) | 2005-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20055207L (no) | Oralt farmasoytisk preparat for protonpumpeantagonister | |
EA201300465A1 (ru) | Устойчивые оральные фармацевтические дозированные формы, содержащие опиоидный анальгетик | |
NO20043367L (no) | Oralt farmasoytisk preparat | |
NO20052739D0 (no) | CCR5-antagonister som medikamenter | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
NO20074037L (no) | Farmasoytiske formuleringer med vedvarende frigivelse | |
NO20063429L (no) | Brusende oral opiat doseringsform | |
SE0301372D0 (sv) | Novel compounds | |
EA200970341A1 (ru) | Пиразолиновые соединения в качестве антагонистов минералокортикоидных рецепторов | |
NO20063393L (no) | Farmasoytiske preparater | |
HK1120442A1 (en) | Novel opioid antagonists | |
CY1109962T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας | |
MA32349B1 (fr) | Antagonistes de la voie hedgehog a base de phtalazines disubstituees | |
TNSN06012A1 (en) | Emulsifying systems containing azetidine derivatives | |
EA201170512A1 (ru) | Композиция для перорального введения | |
NO20063293L (no) | Farmasoytiske forbindelser | |
NO20044448L (no) | Nye forbindelser | |
MXPA05013758A (es) | Composiciones farmaceuticas que incluyen una antihistamina y un estimulante y uso de las mismas. | |
EA201101119A1 (ru) | Дозируемая форма, содержащая пантопразол в качестве активного ингредиента | |
DK1809267T3 (da) | Farmaceutiske kompositioner baseret på NK2-antagonister til pædiatrisk anvendelse | |
EA200501818A1 (ru) | Индазолы, обладающие анальгетической активностью | |
EA201170843A1 (ru) | Предварительно спрессованные быстро распадающиеся лекарственные формы соединений с низкой пероральной биодоступностью | |
ECSP056039A (es) | Formulacion farmaceutica peroral para agentes antagonistas de bombas de protones | |
ATE355830T1 (de) | Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure | |
NL1023797A1 (nl) | Farmaceutische doseringsvorm die zwangerschapsvriendelijke onderscheidingstekens draagt. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104 |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |